Vivo Opportunity, LLC, 10% Owner at InMed Pharmaceuticals Inc. (INM), bought 6,551 shares at $1.54 ($10K) on 2026-06-30, disclosed to the SEC on 2026-07-02.
Open-market purchase of $10k INM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.54 | 55 | $85 | 0.8% |
| 2 | $1.54 | 545 | $839 | 8.3% |
| 3 | $1.55 | 398 | $617 | 6.1% |
| 4 | $1.55 | 3,946 | $6K | 60.3% |
| 5 | $1.55 | 147 | $228 | 2.2% |
| 6 | $1.55 | 1,460 |
| $2K |
| 22.3% |
| Total | $1.55 avg | 6,551 | $10K | 100% |
| Filing → |
| SLNO | SELL | 2024-08-29 | $49.2M | — | Filing → |
| TERN | SELL | 2024-04-03 | $4.9M | — | Filing → |
| TERN | BUY | 2022-09-08 | $2.2M | — | Filing → |